China approves anti-cancer agent by Eisai

Japan based Eisai Co., Ltd. has received New Drug Approval for Eisai’s in-house developed anticancer agent Halaven...

July 18, 2019 | Thursday | News
Abcam acquires EdiGene’s Knock-out cell lines and Lysates Portfolio

Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the acquisition of the entire l...

July 17, 2019 | Wednesday | News
Cipla EU, Jiangsu Acebright enter into Joint Venture

Cipla (EU) Limited, a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited ...

July 16, 2019 | Tuesday | News
I-Mab gets IND approval for TJC4 antibody

I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovat...

July 15, 2019 | Monday | News
First World Longevity Forum and Life Science Conference opens in Hezhou

The First World Longevity Forum and Life Science Conference (WLF&LSC), organized by Hezhou Municipal People's G...

July 15, 2019 | Monday | News
Novena Global Lifecare merges with Xingkeduo for $350M

Novena Global Lifecare, one of the world's largest integrated medical healthcare and aesthetic companies with over 100 c...

July 15, 2019 | Monday | News
MacroGenics and I-Mab to develop, commercialize Enoblituzumab in China

MacroGenics, a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal anti...

July 11, 2019 | Thursday | News
Gilead Sciences to open Western China Operation Center in Chengdu

Chengdu Hi-tech Zone and Gilead Sciences recently inked a strategic cooperation agreement on the Gilead Sciences Western...

July 12, 2019 | Friday | News
CStone announces first patient dosed in China with avapritinib for advanced GIST

CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...

July 10, 2019 | Wednesday | News
AG Mednet, Median Technologies to conduct clinical programs in China

French company Median Technologies, The Imaging Phenomics Company® and US based AG Mednet have renewed their partner...

July 9, 2019 | Tuesday | News
NMPA grants priority review to BeiGene's sNDA for tislelizumab

BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-t...

July 8, 2019 | Monday | News
Nicox inks €12M worth deal with Ocumension Therapeutics

Nicox SA, an international ophthalmology company, and Ocumension Therapeutics have announced they have en...

July 5, 2019 | Friday | News
Incyte and Zai Lab enter into $77.5M collaboration

Incyte and Zai Lab Ltd. has announced that the companies have entered into a collaboration and license agreement fo...

July 8, 2019 | Monday | News
Fosun launches fourth edition of acceleration program Protechting

Fosun and its portfolio companies Fidelidade, Luz Saude and  Hauck & Aufhauser have launched the four...

July 5, 2019 | Friday | News
Chinese Red Cross Foundation initiates Rare Disease Care Movement

On July 2, 2019, Chinese Red Cross Foundation initiated the "Rare Disease Care Movement" in Yinchuan City, Ningxia ...

July 4, 2019 | Thursday | News
Ping An’s insight on Transformative Power of Technology for Finance & Healthcare

The World Economic Forum’s Annual Meeting of the New Champions 2019, also known as the “Summer Davos”,...

July 3, 2019 | Wednesday | News
Asieris, Photocure enter into a license agreement for development and commercialization of Cevira

Asieris MediTech Co, a China-based biotech company specializing in the development and commercialization of ne...

July 3, 2019 | Wednesday | News
Tsinghua University launches Amgen Scholars Program

The Amgen Scholars Program (ASP) at Tsinghua University, funded by the Amgen Foundation, held its opening ceremony recen...

July 3, 2019 | Wednesday | News